South Carolina H 4042: Ivermectin

Bill Text

2025-2026 Bill 4042 Text of Previous Version (May. 14, 2026) - South Carolina Legislature Online 

South Carolina General Assembly
126th Session, 2025-2026

Bill 4042

Indicates Matter Stricken
Indicates New Matter

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

Indicates Matter Stricken

Indicates New Matter

Amended

May 13, 2026

H. 4042

Introduced by Reps. Kilmartin, White, Gilreath, 
Cromer, Guffey, Harris, Hager, McCravy, Edgerton, Terribile, Magnuson, 
Lastinger, D. Mitchell, Sessions, Chapman, Brewer, Lawson, Oremus, Hartz, 
Vaughan, Pedalino, Teeple, Landing, Rankin, Schuessler, Ligon, Long, Sanders, 
Ford, T. Moore, Forrest, Chumley, Bowers, Taylor, Hixon, M. M. Smith, Gibson 
and Duncan 

S. Printed 5/13/26--S. [SEC 
5/14/2026 10:46 AM]

Read the first time May 6, 2026

________

A bill

TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY ADDING SECTION 
44-53-150 SO AS TO AUTHORIZE THE OVER-THE-COUNTER SALE OF IVERMECTIN TABLETS.

 Amend Title To Conform

Be it enacted by the 
General Assembly of the State of South Carolina:

SECTION 1. Article 3, Chapter 53, Title 44 of the S.C. Code is 
amended by adding:

 Section 
44-53-150. (A) Notwithstanding any 
provision of law to the contrary, FDA-approved ivermectin product labeled for 
human use may be made available to the public for over-the-counter purchase in 
this State to any person who is at least eighteen years of age, provided 
ivermectin dispensed pursuant to this section must be maintained in an area 
accessible only to pharmacy personnel. No prescription order shall be required 
for such purchase.

 (B) 
The Board of Pharmacy shall adopt rules to establish standard procedures for 
the dispensing of ivermectin including the following: 

 (1) 
providing the patient with a screening risk assessment tool; 

 (2) 
providing the patient with information on the indications and contraindications 
for the use of ivermectin, the appropriate method for using ivermectin, the 
importance of medical follow-up, and any other information considered 
appropriate by the department; and

 (3) 
prohibitions on dispensing ivermectin when contraindications or clinically 
significant drug interactions exist based on a patient's medication profile or 
medical conditions.

 (C) 
The Board of Pharmacy shall not require documentation beyond that reasonably 
necessary to demonstrate compliance with this section and shall adopt rules 
necessary to implement this section within ninety days of the effective date.

 (D) A 
pharmacist may rely upon information provided by or on behalf of the patient 
when acting pursuant to this section and is not liable for incomplete, 
inaccurate, or omitted information provided by or on behalf of a patient. A 
pharmacist acting in good faith and with reasonable care pursuant to this 
section is immune from disciplinary or adverse administrative actions from the 
Board of Pharmacy and is immune from civil liability in the absence of gross 
negligence or wilful misconduct. A pharmacist shall be deemed to have acted 
with reasonable care when acting in accordance with rules or procedures adopted 
by the Board of Pharmacy pursuant to this section.

 (E) Nothing 
in this section requires a pharmacist to:

 (1) 
dispense ivermectin, when in the pharmacist's professional judgment, dispensing 
may jeopardize the health or safety of the patient; or 

 (2) 
stock ivermectin.

 (F) 
Nothing in this section shall be construed to require a health insurance issuer 
to provide coverage for the cost of ivermectin dispensed pursuant to the 
provisions of this section or to prevent a pharmacist from charging an 
administrative or dispensing fee for the services provided pursuant to this 
section.

SECTION 2. This act takes effect upon approval 
by the Governor.

----XX----

This web page was last updated on May 14, 2026 at 10:47 AM